Biotech

All Articles

ArsenalBio increases $325M, pivots far from former lead resource

.Toolbox Biosciences is actually proceeding up. The cell therapy provider has added on $325 million ...

Lilly- supported fat burning biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually sub...

Aelis' cannabis usage medication flunks phase 2b, steering Indivior to review $100M choice

.Aelis Farma's chances of securing a quick, positive choice on a $one hundred thousand choice remitt...

ProKidney halts stage 3 test certainly not needed for tissue therapy authorization

.ProKidney has quit some of a set of stage 3 tests for its cell therapy for renal condition after ch...

Vaxcyte climbs on 'stunning' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what experts named "magnificent" stage 1/2 data for its 31-valent pneumococcal v...

Recursion's human brain health condition trial reveals insufficient proof of effectiveness

.Recursion has discovered by means of an early test of its tech-enabled approach to medication disco...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Contact it a case of good chemical make up: Acepodia, a biotech based on Nobel Champion science, is...

Praxis epilepsy medicine minimizes confiscations in stage 2 hearing

.Praxis Preciseness Medicines has actually scored an additional midphase win in epilepsy this year, ...

Three execs resign as Dyne posts combined information for DMD prospect

.After getting away a medical hold many years back, Dyne Rehab has actually revealed brand-new stage...

Arrowhead fires off period 3 data in rare metabolic disease in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in advance of a potential showdown with Ionis...